Skip to Main Content
Don't have an account? Create Account

Association Members Receive CDC Funding to Combat Antibiotic Resistance

The Centers for Disease Control and Prevention (CDC) has awarded more than $15 million to 41 investigators through the Antibiotic Resistance Solutions Initiative for research to detect antibiotic resistance, shape treatment and prevention recommendations, and prevent the spread of antibiotic-resistant infections.

Awardees include five association members:

  • Henry Ford Health System, in Detroit, for a study that aims to improve antibiotic selection and reduce excess length of antibiotic therapy through pharmacist-led prescription reviews at the time of discharge;
  • The Ohio State University, in Columbus, Ohio, for three studies that examine antimicrobial use on crops, salmonella production in dairy calves, and antibiotic stewardship education for calf producers;
  • University of California Irvine, in Orange, Calif., for a study that aims to reduce post-discharge invasive Staphylococcus aureus infections;
  • University of Chicago, in Chicago, for a project to design a genetic sequencing panel to identify antibiotic-resistant genes from stool samples; and
  • University of Virginia, in Charlottesville, Va., for two projects: one to examine antibiotic breakpoints for drug-resistant Shigella at a hospital in Bangladesh; and one to explore prevention methods for Carbapenemase-producing Gammaproteobacteria in health care facilities’ plumbing systems.

Solicitation for 2019 awards will begin in March. CDC will host a webinar on the application process for 2019 innovation funding on Nov. 30 from 10 am to noon ET.

Essential hospitals also are participating in CDC’s Antimicrobial Challenge, a yearlong effort to reduce antimicrobial and antibiotic resistance.

Contact Senior Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.

Share

About the Author

Emily Schweich is a communications associate for America's Essential Hospitals.